1. Home
  2. BOW vs SGP Comparison

BOW vs SGP Comparison

Compare BOW & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

N/A

Current Price

$34.09

Market Cap

734.3M

Sector

Finance

ML Signal

N/A

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$24.92

Market Cap

799.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BOW
SGP
Founded
2020
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
734.3M
799.4M
IPO Year
2024
2026

Fundamental Metrics

Financial Performance
Metric
BOW
SGP
Price
$34.09
$24.92
Analyst Decision
Hold
Strong Buy
Analyst Count
7
6
Target Price
$34.33
★ $44.00
AVG Volume (30 Days)
★ 285.4K
108.2K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.26
N/A
EPS
★ 0.96
N/A
Revenue
★ $551,589,000.00
N/A
Revenue This Year
$23.79
N/A
Revenue Next Year
$20.28
N/A
P/E Ratio
$35.52
★ N/A
Revenue Growth
★ 29.58
N/A
52 Week Low
$21.21
$17.06
52 Week High
$35.07
$30.56

Technical Indicators

Market Signals
Indicator
BOW
SGP
Relative Strength Index (RSI) 70.36 43.31
Support Level $33.66 $24.85
Resistance Level $35.07 $26.29
Average True Range (ATR) 0.16 1.43
MACD -0.01 -0.37
Stochastic Oscillator 61.11 29.19

Price Performance

Historical Comparison
BOW
SGP

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: